PD2.02 Pembrolizumab plus Pemetrexed-Platinum for Patients with Metastatic Nonsquamous NSCLC and Liver or Brain Metastases: Results from KEYNOTE-189
Year: 2019
Type: article
Source: Journal of Thoracic Oncology
Authors: M.C. Garassino, S. Gadgeel, E. Esteban, E. Felip, G. Speranza, F. De Angelis, M. Domine, P. Clingan, M.J. Hochmair, S.F. Powell, S.Y.-S. Cheng, H.G. Bischoff, N. Peled, F. Grossi, R.R. Jennens, M. Reck, R. Hui, E.B. Garon, M. Boyer, B. Rubio-Viqueira, S. Novello, T. Kurata, J.E. Gray, A. Cardellino, J. Yang, M.C. Pietanza, D. Rodríguez-Abreu
Institutions: Fondazione IRCCS Istituto Nazionale dei Tumori, University of Michigan, The Barbara Ann Karmanos Cancer Institute, Hospital Universitario Central de Asturias, Vall d'Hebron Institute of Oncology, Hôpital Charles-Le Moyne, Hospital Universitario Fundación Jiménez Díaz, Ludwig Boltzmann Institute for Lung Health, Otto Wagner Hospital, Sanford Health, Sunnybrook Health Science Centre, Tel Aviv University, Soroka Medical Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, German Center for Lung Research, The University of Sydney, Westmead Hospital, University of California, Los Angeles, Chris O’Brien Lifehouse, Hospital Universitario Quirónsalud Madrid, Ospedale San Luigi Gonzaga, University of Turin, Kansai Medical University, Kansai Medical University Hospital, Moffitt Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Universidad de Las Palmas de Gran Canaria, Hospital Universitario Insular de Gran Canaria
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2988979571